Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes
Ilja L. Kruglikov, Philipp E. Scherer
Abstract
To optimize prevention and control of the Coronavirus Disease 2019 (COVID-19), we need to understand why just a small number of infected individuals develop severe forms of COVID-19. Whereas comorbidities such as obesity, type 2 diabetes (T2D), cardiovascular diseases (CVDs), old age of patients, and their ethnicity are recognized as important contributors toward worse disease outcome
Topics & Concepts
MedicineDiseaseImmunologyDiabetes mellitusPathogenesisObesityDysbiosisCoronavirusSystemic inflammationInflammationType 2 diabetesInsulin resistanceCoronavirus disease 2019 (COVID-19)Internal medicineEndocrinologyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesAdipokines, Inflammation, and Metabolic DiseasesDiabetes and associated disorders